Preliminary analysis of a phase II study of Heptazyme™, a nuclease resistant ribozyme targeting hepatitis C virus (HCV) RNA.

被引：0

作者：

Tong, M

Schiff, E

Jensen, DM

Jacobsen, I

Eversen, G

McHutchison, JG

Aitchison, R

Gordon, GS

Babcock, SA

Enright, JH

Maloney, L

Sandberg, JA

Blatt, L

机构：

[1] Huntington Mem Hosp, Pasadena, CA USA

[2] Univ Miami, Sch Med, Miami, FL 33152 USA

[3] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

[4] New York Presbyterian Hosp, New York, NY USA

[5] Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA

[6] Scripps Clin, La Jolla, CA USA

[7] Ribozyme Pharmaceut Inc, Boulder, CO USA

来源：

HEPATOLOGY | 2002年 / 36卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

788

引用

页码：360A / 360A

页数：1

共 50 条

[41] Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis
Watkins-Riedel, T
Ferenci, P
Steindl-Munda, P
Gschwantler, M
Mueller, C
Woegerbauer, M
CLINICAL INFECTIOUS DISEASES, 2004, 39 (12) : 1754 - 1760
[42] SB 9200, A NOVEL IMMUNOMODULATOR FOR PATIENTS WITH VIRAL HEPATITIS: PHASE 1 MAD STUDY IN PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION
Thompson, A.
Roberts, S.
Cheng, W.
Angus, P.
Visvanathan, K.
Iyer, R.
Barclay, M.
JOURNAL OF HEPATOLOGY, 2015, 62 : S283 - S284
[43] Preliminary study of hepatitis C virus RNA kinetic in patients with liver transplantation and treated with interferon plus ribavirin
Barcena-Marugan, R
Garcia, S
Moraleda, G
del Campo-Terron, S
Moreno-Garcia, J
Nuno, A
Fortun, J
de Vicente, E
JOURNAL OF HEPATOLOGY, 2003, 38 : 36 - 36
[44] The Liver MicroRNA Expression Profiles Associated With Chronic Hepatitis C Virus (HCV) Genotype-4 Infection: A Preliminary Study
El-Guendy, Nadia Mohamed
Helwa, Reham
El-Halawany, Medhat Salah
Ali, Shimaa Abdel Rahman
Aly, Marwa Tantawy
Alieldin, Nelly Hasan
Fouad, Shawky Abdel Hamid
Saeid, Hany
Abdel-Wahab, Abdel-Hady Ali
HEPATITIS MONTHLY, 2016, 16 (04)
[45] Preliminary report of a controlled trial of MTH-68/B™ virus vaccine treatment in acute B and C hepatitis:: A phase II study
Csatary, LK
Telegdy, L
Gergely, P
Bodey, B
Bakács, T
ANTICANCER RESEARCH, 1998, 18 (2B) : 1279 - 1282
[46] Analysis of hepatitis C virus (HCV) RNA in the lesions of lichen planus in patients with chronic hepatitis C: detection of anti-genomic- as well as genomic-strand HCV RNAs in lichen planus lesions
Kurokawa, M
Hidaka, T
Sasaki, H
Nishikata, I
Morishita, K
Setoyama, M
JOURNAL OF DERMATOLOGICAL SCIENCE, 2003, 32 (01) : 65 - 70
[47] Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy (vol 137, pg 417, 2004)
Tsubouchi, E
Akbar, SMF
Murakami, H
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (01): : 193 - 193
[48] HCV-FiS (HEpatitis C Virus Finger-stick Study): HCV RNA point-of-care testing by GeneXpert in the setting of DAA therapy
Bronte, F.
Calvaruso, V.
Ferraro, D.
Petta, S.
Magro, B.
Di Marco, V.
Craxi, A.
DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 58 - 58
[49] HCV-FiS (HEpatitis C Virus Finger-stick Study): HCV RNA point-of-care testing by GeneXpert in the setting of DAA therapy
Calvaruso, V.
Bronte, F.
Ferraro, D.
Bavetta, M. G.
Petta, S.
Marco, V. D.
Craxi, A.
JOURNAL OF HEPATOLOGY, 2018, 68 : S255 - S256
[50] Impact of pre-transplant serum hepatitis C virus (HCV)-RNA negativity on post-transplant outcome in patients with HCV-related cirrhosis: A study including intra hepatic HCV-RNA study.
Sobesky, Rodolphe
Maylin, Sarah
Francoz, Claire
Moucari, Rami
Martinot, Michele
Marcellin, Patrick
Paradis, Valerie
Belghiti, Jacques
Valla, Dominique
Durand, Francois
LIVER TRANSPLANTATION, 2007, 13 (06) : S150 - S150

← 1 2 3 4 5 →